KOR ENG

HOME

  • menubar
  • menubar
  • menubar

News & Events

Based on a competitive edge that meets the needs of the Korean sample analysis market, GCCL is expanding its horizons to the global markets. We are committed to listening to the voices of our clients and expanding into the global market together.

Press Release

홈   >   News & Events   >   Press Release

Search

2023. 03. 18

[PR] GCCL Develops PBMC Resource Management System

GCCL Develops PBMC Resource Management SystemTo enhance accuracy and credibility of sample management and provide real-time information for customersGCCL(Global Clinical Central Lab), a company specializes in clinical trial sample analysis, announced on Mar.17 that it has built a resource management system for Peripheral Blood Mononuclear Cells (PBMCs), or PBMC Resource Management System.Under the PBMC Resource Management System, the whole process of PBMC testing, from the arrival of an original sample, centrifugation, and production of vials for split sample PBMC, to storage, dispatch mapping and disposal, is managed and stored in a computerized system using 2 barcodes.The system creates exclusive barcodes for each original and split samples after mapping, and the end-to-end testing cycle is computerized in the system. This will prevent human errors from manual entry and allow real-time data provision upon customer request."With more and more clinical trials for new biologic drug development, such as immunotherapy drugs require Cell Mediated Immunogenicity (CMI) analysis, we have decided to build this IT system to ensure excellent PBMC production and management services for customers.", said Hee-Joo Lee, Vice President of GCCL Lab Operation. She added, "This system development is expected to bring safer, more efficient and credible sample management services."About GCCLGCCL, a Good Clinical Laboratory Practice(GCLP)-certified agency accredited by the Ministry of Food and Drug Safety of South Korea, is a clinical trial sample analysis company that provides services for all phases of clinical trials from phase 1 to 4. Based on its variety of analysis platforms that meets the global quality standards and its own sample logistics system, the company is providing clinical trial sample analysis services for its partners across Asia and beyond.PR Newswire (https://www.prnewswire.com/news-releases/gccl-develops-pbmc-resource-management-system-301774708.html)

Read more

2022. 05. 31

[PR] GCCL launches vaccine and treatment neutralizing antibody titers' analysis service

GCCL launches vaccine and treatment neutralizing antibody titers' analysis serviceGlobal Clinical Central Lab (GCCL), a subsidiary of GC Cell, said it would provide an analysis service of neutralizing antibodies of vaccines and therapeutic agents for infectious viral diseases from June.Only specialized institutions equipped with biosafety knowledge and analytical technology can perform neutralizing antibody analysis using live viruses.The services introduced by the lab include two methods -- plaque reduction neutralization test (PRNT) and the focus reduction neutralization test (FRNT)-- preferentially required when confirming the efficacy of a substance during clinical trials. The lab stressed that both assays have advantages such as high reproducibility and objectivity.Notably, the FRNT method reduces the measurement time of neutralizing antibodies, which normally takes about five to 10 days, to two to three days. Also, it allows simultaneous measurement of multiple neutralizing antibodies, according to GCCL.The lab explained that after establishing this analysis service, it has completed verification using the World Health Organization (WHO) standard serum used to verify the service and will be able to provide services from basic research fields, such as live virus-based candidate material verification and disease model research to research fields requiring various special facilities."The lab expects to help developers conduct clinical trials for developers, as they struggle with a lack of neutralizing antibody analysis facilities for new and mutated infectious disease," said Hee-Joo Lee, head of GCCL Lab Operations. "We will continue to expand various services for our customers."GCCL is a good clinical laboratory practice (GCLP)-certified laboratory that provides full-cycle analysis services from phase 1 to phase 4 clinical trials.Based on the company's sample transport and logistics system and various analysis platforms that meet global quality standards, the company supports the analysis of clinical trial samples from partners in Asia and around the world, GCCL said.About GCCLGCCL, a Good Clinical Laboratory Practice(GCLP)-certified agency accredited by the Ministry of Food and Drug Safety of South Korea, is a clinical trial sample analysis company that provides services for all phases of clinical trials from phase 1 to 4. Based on its variety of analysis platforms that meets the global quality standards and its own sample logistics system, the company is providing clinical trial sample analysis services for its partners across Asia and beyond.Korea Biomedical Review (https://www.koreabiomed.com/news/articleView.html?idxno=13784)

Read more
<1>